HomeCompareCDPYF vs KMB

CDPYF vs KMB: Dividend Comparison 2026

CDPYF yields 4.39% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CDPYF wins by $1589.68M in total portfolio value
10 years
CDPYF
CDPYF
● Live price
4.39%
Share price
$25.55
Annual div
$1.12
5Y div CAGR
96.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1589.73M
Annual income
$1,511,908,437.31
Full CDPYF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — CDPYF vs KMB

📍 CDPYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDPYFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDPYF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDPYF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDPYF
Annual income on $10K today (after 15% tax)
$372.77/yr
After 10yr DRIP, annual income (after tax)
$1,285,122,171.71/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, CDPYF beats the other by $1,285,117,732.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDPYF + KMB for your $10,000?

CDPYF: 50%KMB: 50%
100% KMB50/50100% CDPYF
Portfolio after 10yr
$794.89M
Annual income
$755,956,829.83/yr
Blended yield
95.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

CDPYF
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$54.00
+111.4% upside vs current
Range: $54.00 — $54.00
Altman Z
1.1
Piotroski
7/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDPYF buys
0
KMB buys
0
No recent congressional trades found for CDPYF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDPYFKMB
Forward yield4.39%5.25%
Annual dividend / share$1.12$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR96.8%17%
Portfolio after 10y$1589.73M$45.9K
Annual income after 10y$1,511,908,437.31$5,222.34
Total dividends collected$1584.14M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$54.00$123.00

Year-by-year: CDPYF vs KMB ($10,000, DRIP)

YearCDPYF PortfolioCDPYF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$11,563$863.06$11,314$614.45+$249.00CDPYF
2$14,208$1,835.51$12,867$760.19+$1.3KCDPYF
3$19,351$4,148.18$14,713$945.27+$4.6KCDPYF
4$31,096$10,391.14$16,924$1,181.90+$14.2KCDPYF
5$63,986$30,712.68$19,596$1,486.64+$44.4KCDPYF
6$184,699$116,233.86$22,850$1,882.16+$161.8KCDPYF
7$814,725$617,097.73$26,849$2,399.80+$787.9KCDPYF
8$5,878,353$5,006,596.83$31,812$3,083.36+$5.85MCDPYF
9$72,729,645$66,439,807.44$38,033$3,994.72+$72.69MCDPYF
10$1,589,729,158$1,511,908,437.31$45,918$5,222.34+$1589.68MCDPYF

CDPYF vs KMB: Complete Analysis 2026

CDPYFStock

CAPREIT is one of Canada's largest real estate investment trusts. CAPREIT owns approximately 57,000 suites, including townhomes and manufactured housing sites, in Canada and, indirectly through its investment in ERES, approximately 5,800 suites in the Netherlands. CAPREIT manages approximately 61,200 of its owned suites in Canada and Netherlands, and additionally approximately 3,800 suites in Ireland as at September 30, 2020.

Full CDPYF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this CDPYF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDPYF vs SCHDCDPYF vs JEPICDPYF vs OCDPYF vs KOCDPYF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.